Wilcock G

References (9)

Title : Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial - Green_2009_JAMA_302_2557
Author(s) : Green RC , Schneider LS , Amato DA , Beelen AP , Wilcock G , Swabb EA , Zavitz KH
Ref : Jama , 302 :2557 , 2009
PubMedID: 20009055

Title : Donepezil for the treatment of agitation in Alzheimer's disease - Howard_2007_N.Engl.J.Med_357_1382
Author(s) : Howard RJ , Juszczak E , Ballard CG , Bentham P , Brown RG , Bullock R , Burns AS , Holmes C , Jacoby R , Johnson T , Knapp M , Lindesay J , O'Brien JT , Wilcock G , Katona C , Jones RW , DeCesare J , Rodger M
Ref : N Engl J Med , 357 :1382 , 2007
PubMedID: 17914039

Title : Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies - Ballard_2007_Neurology_68_1726
Author(s) : Ballard CG , Chalmers KA , Todd C , McKeith IG , O'Brien JT , Wilcock G , Love S , Perry EK
Ref : Neurology , 68 :1726 , 2007
PubMedID: 17502555

Title : Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology - Burns_2006_J.Psychopharmacol_20_732
Author(s) : Burns A , O'Brien J , Auriacombe S , Ballard C , Broich K , Bullock R , Feldman H , Ford G , Knapp M , McCaddon A , Iliffe S , Jacova C , Jones R , Lennon S , McKeith I , Orgogozo JM , Purandare N , Richardson M , Ritchie C , Thomas A , Warner J , Wilcock G , Wilkinson D
Ref : J Psychopharmacol , 20 :732 , 2006
PubMedID: 17060346

Title : Evidence-based pharmacotherapy of Alzheimer's disease - Evans_2004_Int.J.Neuropsychopharmacol_7_351
Author(s) : Evans JG , Wilcock G , Birks J
Ref : Int J Neuropsychopharmacol , 7 :351 , 2004
PubMedID: 15228642

Title : The second Leicester survey of memory clinics in the British Isles - Lindesay_2002_Int.J.Geriatr.Psychiatry_17_41
Author(s) : Lindesay J , Marudkar M , Van Diepen E , Wilcock G
Ref : Int J Geriatr Psychiatry , 17 :41 , 2002
PubMedID: 11802229

Title : Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration - Qizilbash_1998_Jama_280_1777
Author(s) : Qizilbash N , Whitehead A , Higgins J , Wilcock G , Schneider L , Farlow M
Ref : Jama , 280 :1777 , 1998
PubMedID: 9842955

Title : The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease - Kehoe_1998_J.Med.Genet_35_1034
Author(s) : Kehoe PG , Williams H , Holmans P , Wilcock G , Cairns NJ , Neal J , Owen MJ
Ref : Journal of Medical Genetics , 35 :1034 , 1998
PubMedID: 9863603

Title : Tacrine for Alzheimer's disease: why is it not available on prescription to UK sufferers? -
Author(s) : Wilcock G
Ref : Age Ageing , 23 :353 , 1994
PubMedID: 7825478